The historical rank and industry rank for Rockwell Medical's OCF Margin % or its related term are showing as below:
FRA:RWMA'
s OCF Margin % Range Over the Past 10 Years
Min: -54.15 Med: -27.79 Max: 4.14
Current: 3.95
During the past 13 years, the highest OCF Margin % of Rockwell Medical was 4.14%. The lowest was -54.15%. And the median was -27.79%.
FRA:RWMA's OCF Margin % is ranked worse than 63.92% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs FRA:RWMA: 3.95
Rockwell Medical OCF Margin % Related Terms
Rockwell Medical OCF Margin % Historical Data
* Premium members only.
The historical data trend for Rockwell Medical's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:RWMA vs MRMD, CPHI, HYEX: OCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Rockwell Medical's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rockwell Medical OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Rockwell Medical's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Rockwell Medical's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rockwell Medical (FRA:RWMA) has a OCF Margin % of -0.96% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Rockwell Medical and its competitors. According to the industry distribution chart, Rockwell Medical ranks #613 out of 959 companies in the Drug Manufacturers industry, placing it in the top 63.9%.
Is Rockwell Medical's OCF Margin % too high?
Rockwell Medical's current OCF Margin % is -0.96%. Based on the distribution chart, Rockwell Medical ranks #613 out of 959 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Rockwell Medical has a GF Score™ of 30/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rockwell Medical's OCF Margin % compare to MRMD and CPHI?
According to the Drug Manufacturers industry distribution chart, Rockwell Medical ranks #613 out of 959 companies for OCF Margin %. This places Rockwell Medical in the lower half of its industry. The industry median OCF Margin % is 9.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Rockwell Medical and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rockwell Medical's current OCF Margin % is -0.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rockwell Medical stock overvalued right now?
Based on GuruFocus' analysis, Rockwell Medical (FRA:RWMA) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.75, compared to a current price of €0.59 — trading 22% below its estimated fair value. The current OCF Margin % is -0.96%. Rockwell Medical's overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Rockwell Medical (FRA:RWMA), the current OCF Margin % is -0.96% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rockwell Medical (FRA:RWMA) Overvalued in 2026?
Based on GuruFocus' analysis, Rockwell Medical stock appears to be undervalued.
The current stock price of €0.59 is trading 22% below its estimated GF Value™ of €0.75.
GuruFocus considers Rockwell Medical to be Modestly Undervalued.
Key valuation signals for FRA:RWMA:
OCF Margin %: -0.96%
GF Value™: €0.75 vs. price of €0.59 (22% below fair value)
No single metric tells the full story. See the FRA:RWMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
30GF Score
Get the complete analysis for FRA:RWMA
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:RWMA has been successfully added to your 
